Core Viewpoint - The article highlights the upcoming listing of Jianfa Zhixin Medical Technology Group Co., Ltd. on the Shenzhen Stock Exchange, emphasizing its role as a state-owned enterprise and a national high-value medical device distributor, focusing on direct sales and distribution, as well as providing centralized operation services for medical consumables [1]. Industry Overview - The medical device market is experiencing continuous growth driven by factors such as an aging population, rising chronic disease rates, and improved health awareness among residents [2]. - Despite the promising outlook, the medical device distribution sector faces significant challenges, including a fragmented supply chain, low operational efficiency, and issues with product identification and data standardization [2][3]. Company Innovations - Jianfa Zhixin is innovating through a "national integrated medical device distribution hub" model, which aims to improve management costs and efficiency while addressing traceability issues in the distribution of medical consumables [4][5]. - The company has developed a centralized management system for medical consumables, enhancing operational efficiency and reducing human resource demands through automation and smart technology [5][7]. Market Position and Growth - Jianfa Zhixin has strategically positioned itself in the high-value medical consumables market, achieving significant growth with contracts signed for centralized operation services with 60 hospitals, managing over 10 billion yuan in medical consumables [9]. - The company has reported impressive revenue growth, with projected revenues of 118.82 billion yuan in 2022, 154.43 billion yuan in 2023, and 179.23 billion yuan in 2024, reflecting a compound annual growth rate of 22.81% from 2022 to 2024 [9][10]. Competitive Advantage - Jianfa Zhixin's innovative solutions and operational efficiency have positioned it as a leader in the medical device distribution industry, with the highest revenue growth rate among major competitors [10][11]. - The company's focus on addressing industry pain points through its integrated distribution model and advanced supply chain management systems has garnered market recognition and facilitated rapid project implementation [11].

Core Viewpoint - Jianfa Zhixin (301584) successfully held its online roadshow for its initial public offering (IPO) on the ChiNext board, with subscription starting on September 16 [1] Group 1: Company Overview - Jianfa Zhixin was founded in 2010 and is headquartered in Shanghai, being a member of Jianfa Group [1] - The company operates as a national medical device distributor, focusing on direct sales and distribution of medical devices, as well as providing centralized operation services for medical consumables to hospitals [1] - Jianfa Zhixin has established long-term stable partnerships with over 100 well-known domestic and international high-value medical device manufacturers [1] Group 2: Business Model and Innovation - The company has developed a unique and innovative business model by addressing pain points in traditional medical device distribution and exploring the needs across the industry chain [2] - Jianfa Zhixin leverages modern technologies such as information management, IoT, and big data to enhance its management and service models, providing more modernized distribution services for the medical device industry [2] - The company's core competitiveness is built on innovations in technology, service, and management, reflecting its characteristics of innovation, creativity, and technical advancement [2]